M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.89 USD -1.35% Market Closed
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MoonLake Immunotherapeutics
Net Income (Common) Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Net Income (Common)
-$36m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Net Income (Common)
-$240.1m
CAGR 3-Years
1%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Net Income (Common)
-CHf60.5m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Net Income (Common)
-$239.6m
CAGR 3-Years
N/A
CAGR 5-Years
-84%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Net Income (Common)
-CHf69.1m
CAGR 3-Years
1%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Net Income (Common)
CHf14.9m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Net Income (Common)?
Net Income (Common)
-36m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Net Income (Common) amounts to -36m USD.

What is MoonLake Immunotherapeutics's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
28%

Over the last year, the Net Income (Common) growth was 28%.

Back to Top